Kyn Therapeutics Appoints Douglas Carlson as Chief Financial Officer
Go back to Kyn Therapeutics Appoints Douglas Carlson as Chief Financial Officer| (NASDAQ: COLL) | Delayed: 22.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.11 | 52 Week High | $30.58 | |||
| Open | $22.11 | 52 Week Low | $8.24 | |||
| Day High | $22.11 | P/E | N/A | |||
| Day Low | $22.11 | EPS | $0.00 | |||
| Volume | 2,315 | |||||



